Abilify | Search

Accessibility help Skip to navigation Skip to content Skip to footer

Showing results for Abilify

Sort by

Viewing results 1‒18 of 18

US & Canadian companies
US regulators approve first digital pill with tracking system
...The technology, developed over 10 years by Silicon Valley-based Proteus Digital Health, will be incorporated into an existing antipsychotic drug, Abilify, made by Japanese drugmaker Otsuka Pharmaceutical...
November 14, 2017
Pharmaceuticals sector
Otsuka and Proteus extend digital drugs tie-up
...The tie-up with Proteus Digital Health builds on US approval last year for the technology to be used in an existing antipsychotic drug made by Otsuka called Abilify, marking the first time that a medication...
October 11, 2018
FT Live
US Pharma and Biotech Summit
Strategies for innovation, pricing and access
Thursday, 16 MayNew York, NY, USA
News in-depthCompanies2 min
Tracking tablets: digital pill knows when it has been taken
...This so-called smart pill is prescribed for schizophrenia and is called Abilify Mycite. The action starts when the pill, which contains a tiny sensor, hits stomach fluids....
February 14, 2018
News in-depthPharmaceuticals sector
Digital pill offers chance of new life to old drugs
...This month the US Food and Drug Administration gave the green light to Otsuka Pharmaceutical to market a version of its antipsychotic drug Abilify that has an ingestible sensor embedded in the tablet....
November 22, 2017
US & Canadian companies
US regulators accept ‘chip in a pill’ application
...The combination with Otsuka’s Abilify marks the first approved drug to be filed for review as a digital medicine....
September 10, 2015
US & Canadian companies
Otsuka to buy US maker of promising Alzheimer drug
...Abilify, a treatment for schizophrenia and depression, generates about 40 per cent of the company’s $12bn in annual revenue....
December 2, 2014
FT Live
Global Pharma and Biotech Summit
Driving life sciences innovation in a disrupted world
Tuesday, 5 NovemberIn-Person & Online Conference
LexPharmaceuticals sector
Bristol-Myers Squibb: side effects
...Were it not for one big drug – the antipsychotic Abilify, which is past patent expiry – growth would look better. And the company has long focused on shareholder returns, paying a meaty dividend....
April 1, 2014
Companies By Region
Japan’s Otsuka Pharmaceutical set to buy US drugmaker Astex
...As well as nutrition products, the company makes Abilify, a drug used to treat schizophrenia and bipolar disorder, prescriptions of which have been increasing in China and the US....
September 5, 2013
Observations
Douglas Coupland: Drugs
...These days we have Abilify, Celexa, Zoloft and . . . all these other bafflingly named pills I learn about mostly while I’m fast-forwarding through TV ads on TiVo....
March 21, 2014
FT AlphavilleUK airports
The 6am Cut London
...The review into drug use by recipients aged 17 and under “applies to a newer class of antipsychotic drugs known as “atypicals,” which include Abilify, the nation’s No. 1 prescription drug by sales”....
August 12, 2013
Semiconductors
US steelmakers dragged by weak forecasts
...Lower taxes and cost cuts boosted profits but revenues disappointed investors because of weak sales of Abilify, its schizophrenia treatment, which has been the company’s growth driver in recent years, as...
October 26, 2010
US & Canadian companies
Cost cuts buoy drug groups’ profits
...BMS reported revenues of $5.49bn against $5.25bn in the same quarter a year earlier, helped by strong sales of its blood thinner Plavix, antipsychotic Abilify, rheumatoid arthritis treatment Orencia, and...
October 22, 2009
US & Canadian companies
Pfizer and BMS beat earnings expectations
...First quarter net income from continuing operations at BMS rose 5 per cent to $921 or 32 cents per share, led by sales of antipsychotic Abilify, anticoagulant Plavix, rheumatoid arthritis treatment Orencia...
April 28, 2009
Mergers & Acquisitions
Bank stocks drag Wall Street lower
...Bristol-Myers Squibb, the pharmaceutical company, performed well after it renegotiated a licensing agreement with Japan’s Otsuka Pharmaceutical to sell the Abilify schizophrenia drug for an extra 29 months...
April 6, 2009
US & Canadian companies
Eli Lilly reports loss after Zyprexa charge
...Revenue from Abilify, prescribed for bipolar disorder and schizophrenia, rose 34 per cent to $564m. The two drugs make up a third of Bristol-Myers’ revenue, with sales of about $6.42bn last year....
October 23, 2008
FT Live
FTWeekend Festival: U.S. edition
Where the Financial Times weekend paper comes to life
Saturday, 4 MayThe REACH, at the Kennedy Center for the Performing Arts, F Street Northwest, Washington, DC, USA
World
Bristol-Myers expected to settle federal probe
...However, it has several new drugs, such as the antipsychotic Abilify and diabetes treatment muraglitazar, to help its recovery....
June 6, 2005
US & Canadian companies
Eli Lilly sets up $690m Zyprexa litigation fund
...Reports of diabetic side effects and litigation gave ammunition to Lilly's competitors, including Bristol-Myers Squibb's Abilify, AstraZeneca's Seroquel, and Johnson & Johnson's Risperdal....
June 10, 2005
Mergers & Acquisitions
Bristol-Myers suffers side-effects from rival drugs
...But sales of recently launched schizophrenia treatment Abilify jumped 63 percent to $165 million, helped by its better safety profile than rival treatments....
October 29, 2004

Previous pagePage 1 of 1Next page